Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 25, 2011) - biOasis Technologies Inc. (TSX VENTURE:BTI) is pleased to announce a non-brokered private placement of up to 2,250,000 units at...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 24, 2011) - biOasis Technologies Inc. (TSX VENTURE:BTI) announced today that it has entered into a research, evaluation and option...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 1, 2011) - biOasis Technologies Inc. (TSX VENTURE:BTI) today announced test results from its Transcend therapeutic development program...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Oct. 17, 2011) - biOasis Technologies Inc. (TSX VENTURE:BTI) announced today the results from two additional studies conducted by the BC Cancer...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 2, 2011) - biOasis Technologies Inc. (TSX VENTURE:BTI) announces that it has grated options to its officers, employees, consultants and...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 18, 2011) - biOasis Technologies Inc. (TSX VENTURE:BTI) announces its board of directors elected by the shareholders at its recently held...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 16, 2011) - biOasis Technologies Inc. (TSX VENTURE:BTI) announced today positive results from its BT2111 program showing that the company's...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 10, 2011) - biOasis Technologies Inc. (TSX VENTURE:BTI) (the "Company") announces that its wholly owned subsidiary biOasis Advanced...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 5, 2011) - biOasis Technologies Inc. (TSX VENTURE:BTI) (the "Company") announces that its wholly owned subsidiary biOasis Advanced Technologies...
-
VANCOUVER, B.C., July 6, 2011 (GLOBE NEWSWIRE) -- biOasis Technologies Inc. (TSX-V:BTI) today announced results from two studies designed to assess the therapeutic potential of its Transcend vector in...